The 2 most common causes of death in the United States are cancer and heart disease. Screening, defined as the process of proactively identifying disease risk, is pursued as part of routine medical care of adults. Standardized imaging-based screening (eg, mammography), procedure-based screening (eg, colonoscopy), and laboratory-based screening (eg, measurement of blood cholesterol levels) exist for cancer and heart disease; however, there is not currently any recommended use of DNA-based screening in these disease areas.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Murray MF, Evans JP, Khoury MJ. DNA-Based Population Screening: Potential Suitability and Important Knowledge Gaps. JAMA. 2020;323(4):307–308. doi:10.1001/jama.2019.18640
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: